Beat

Biotech

Biology, medicine, and the technology extending human capability.

6 stories
Biotech

The protein folding revolution, three years later: what AlphaFold actually changed

DeepMind's structure prediction tool has been used in 2 million research projects.

Apr 23, 2026 . 1 min . Read story
Biotech

Ozempic’s patent cliff is about to change the global drug market

Semaglutide's primary patents expire between 2026 and 2031, opening the market to biosimilars.

Apr 23, 2026 . 1 min
Biotech

GLP-1 drugs are now being used for addiction. The research is startling.

Semaglutide and tirzepatide are showing strong efficacy against alcohol, nicotine, and opioid addiction in early trials.

Apr 23, 2026 . 1 min
Biotech

mRNA flu vaccines are coming — here’s what the trials show

After COVID mRNA vaccines, Moderna and Pfizer have completed Phase 3 trials for influenza with substantially better efficacy.

Apr 23, 2026 . 1 min
Biotech

The longevity startup that thinks it can reverse aging by 20 years — and has data

Altos Labs' first human trial data shows statistically significant improvement on biological age markers.

Apr 23, 2026 . 1 min
Biotech

CRISPR’s first approved gene therapy for sickle cell disease: one year in

Vertex and CRISPR Therapeutics' Casgevy is now in the hands of 340 patients.

Apr 23, 2026 . 1 min